Literature DB >> 11533200

Chimeric bovine respiratory syncytial virus with attachment and fusion glycoproteins replaced by bovine parainfluenza virus type 3 hemagglutinin-neuraminidase and fusion proteins.

M B Stope1, A Karger, U Schmidt, U J Buchholz.   

Abstract

Chimeric bovine respiratory syncytial viruses (BRSV) expressing glycoproteins of bovine parainfluenza virus type 3 (BPIV-3) instead of BRSV glycoproteins were generated from cDNA. In the BRSV antigenome cDNA, the open reading frames of the major BRSV glycoproteins, attachment protein G and fusion protein F, were replaced individually or together by those of the BPIV-3 hemagglutinin-neuraminidase (HN) and/or fusion (F) glycoproteins. Recombinant virus could not be recovered from cDNA when the BRSV F open reading frame was replaced by the BPIV-3 F open reading frame. However, cDNA recovery of the chimeric virus rBRSV-HNF, with both glycoproteins replaced simultaneously, and of the chimeric virus rBRSV-HN, with the BRSV G protein replaced by BPIV-3 HN, was successful. The replication rates of both chimeras were similar to that of standard rBRSV. Moreover, rBRSV-HNF was neutralized by antibodies specific for BPIV-3, but not by antibodies specific to BRSV, demonstrating that the BRSV glycoproteins can be functionally replaced by BPIV-3 glycoproteins. In contrast, rBRSV-HN was neutralized by BRSV-specific antisera, but not by BPIV-3 specific sera, showing that infection of rBRSV-HN is mediated by BRSV F. Hemadsorption of cells infected with rBRSV-HNF and rBRSV-HN proved that BPIV-3 HN protein expressed by rBRSV is functional. Colocalization of the BPIV-3 glycoproteins with BRSV M protein was demonstrated by confocal laser scan microscopy. Moreover, protein analysis revealed that the BPIV-3 glycoproteins were present in chimeric virions. Taken together, these data indicate that the heterologous glycoproteins were not only expressed but were incorporated into the envelope of recombinant BRSV. Thus, the envelope glycoproteins derived from a member of the Respirovirus genus can together functionally replace their homologs in a Pneumovirus background.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11533200      PMCID: PMC114505          DOI: 10.1128/JVI.75.19.9367-9377.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Homooligomerization of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3 occurs before the acquisition of correct intramolecular disulfide bonds and mature immunoreactivity.

Authors:  P L Collins; G Mottet
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

2.  Quantitation of protein.

Authors:  C M Stoscheck
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

3.  Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins.

Authors:  B García-Barreno; C Palomo; C Peñas; T Delgado; P Perez-Breña; J A Melero
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

4.  Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus.

Authors:  S Levine; R Klaiber-Franco; P R Paradiso
Journal:  J Gen Virol       Date:  1987-09       Impact factor: 3.891

5.  Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein.

Authors:  E E Walsh; J Hruska
Journal:  J Virol       Date:  1983-07       Impact factor: 5.103

6.  The stabilization and purification of respiratory syncytial virus using MgSO4.

Authors:  B F Fernie; J L Gerin
Journal:  Virology       Date:  1980-10-15       Impact factor: 3.616

7.  Nucleotide sequence analysis and expression from recombinant vectors demonstrate that the attachment protein G of bovine respiratory syncytial virus is distinct from that of human respiratory syncytial virus.

Authors:  R A Lerch; K Anderson; G W Wertz
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

8.  Respiratory syncytial virus envelope glycoprotein (G) has a novel structure.

Authors:  M Satake; J E Coligan; N Elango; E Norrby; S Venkatesan
Journal:  Nucleic Acids Res       Date:  1985-11-11       Impact factor: 16.971

9.  Purification of human respiratory syncytial virus: superiority of sucrose gradient over percoll, renografin, and metrizamide gradients.

Authors:  A Mbiguino; J Menezes
Journal:  J Virol Methods       Date:  1991 Feb-Mar       Impact factor: 2.014

10.  Direct observation of the budding and fusion of an enveloped virus by video microscopy of viable cells.

Authors:  T Bächi
Journal:  J Cell Biol       Date:  1988-11       Impact factor: 10.539

View more
  12 in total

1.  The human respiratory syncytial virus matrix protein is required for maturation of viral filaments.

Authors:  Ruchira Mitra; Pradyumna Baviskar; Rebecca R Duncan-Decocq; Darshna Patel; Antonius G P Oomens
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

2.  Mucosal immunization with live recombinant bovine respiratory syncytial virus (BRSV) and recombinant BRSV lacking the envelope glycoprotein G protects against challenge with wild-type BRSV.

Authors:  Ulrike Schmidt; Jörg Beyer; Ulf Polster; Laurel J Gershwin; Ursula J Buchholz
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Roles of the fusion and hemagglutinin-neuraminidase proteins in replication, tropism, and pathogenicity of avian paramyxoviruses.

Authors:  Shin-Hee Kim; Madhuri Subbiah; Arthur S Samuel; Peter L Collins; Siba K Samal
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

4.  Envelope targeting: hemagglutinin attachment specificity rather than fusion protein cleavage-activation restricts Tupaia paramyxovirus tropism.

Authors:  Christoph Springfeld; Veronika von Messling; Christian A Tidona; Gholamreza Darai; Roberto Cattaneo
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  The cytoplasmic tail of the human respiratory syncytial virus F protein plays critical roles in cellular localization of the F protein and infectious progeny production.

Authors:  Antonius G P Oomens; Kevin P Bevis; Gail W Wertz
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

6.  Infectivity of a human respiratory syncytial virus lacking the SH, G, and F proteins is efficiently mediated by the vesicular stomatitis virus G protein.

Authors:  A G P Oomens; A G Megaw; G W Wertz
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

7.  The Respiratory Syncytial Virus Phosphoprotein, Matrix Protein, and Fusion Protein Carboxy-Terminal Domain Drive Efficient Filamentous Virus-Like Particle Formation.

Authors:  Chetan D Meshram; Pradyumna S Baviskar; Cherie M Ognibene; Antonius G P Oomens
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

8.  trans-Complementation allows recovery of human respiratory syncytial viruses that are infectious but deficient in cell-to-cell transmission.

Authors:  A G P Oomens; Gail W Wertz
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Development of measles virus-based shielded oncolytic vectors: suitability of other paramyxovirus glycoproteins.

Authors:  A W Hudacek; C K Navaratnarajah; R Cattaneo
Journal:  Cancer Gene Ther       Date:  2013-01-11       Impact factor: 5.987

10.  The M, F and HN genes of genotype VIId Newcastle disease virus are associated with the severe pathological changes in the spleen of chickens.

Authors:  Yan Kai; Zenglei Hu; Haixu Xu; Shunlin Hu; Jie Zhu; Jiao Hu; Xiaoquan Wang; Xiaowen Liu; Xiufan Liu
Journal:  Virol J       Date:  2015-09-04       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.